Discover 4,573 paid clinical trials in New York State. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
New York State presents a wide array of paid research opportunities for both healthy volunteers and those with specific health concerns. Actively recruiting research institutions in New York City, Buffalo, and Rochester offer access to innovative treatments and exceptional medical care near you.
Filter
1
Filter results
Results: 4,573
Interstitial Photodynamic Therapy Following Palliative Radiotherapy in Treating Patients With Inoperable Malignant Central Airway Obstruction
for
Malignant Solid Neoplasm
Location: Philadelphia PA, Buffalo NY
Sponsor: Roswell Park Cancer Institute
Sex: All
Age: 18+
Code: NCT06306638
Phase 1, Phase 2, Recruiting
Study of Neoadjuvant Chemotherapy Plus Trastuzumab and Pertuzumab in HER2-Negative Breast Cancer Patients With Abnormal HER2 Signaling
for
HER2-negative Breast Cancer
Location: Newark NJ, Baltimore MD, York PA, Mechanicsville VA,
Sponsor: NSABP Foundation Inc
Sex: Female
Age: 18+
Code: NCT03412643
Phase 2, Recruiting
A Prospective Research Investigation of Ischemia Using MCG
for
Acute Coronary Syndrome
Location: New York NY, Rochester MN
Sponsor: SB Technology, Inc.
Sex: All
Age: 18+
Code: NCT06481943
Recruiting
Early Conversion From CNI to Belatacept in Renal Transplant Recipients With Delayed and Slow Graft Function
for
Delayed Graft Function, Kidney Transplant
Location: New York NY
Sponsor: Nair, Vinay, D.O.
Sex: All
Age: 18 - 70
Code: NCT01837043
Phase 2, Recruiting
A Study Collecting Health Information to Understand and Prevent Gastric Cancer
Early Feasibility Study of the Cardiac Implants Percutaneous Ring Annuloplasty System
for
Tricuspid Regurgitation Functional
Location: New York NY
Sponsor: Cardiac Implants LLC
Sex: All
Age: 18+
Code: NCT04890821
Recruiting
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML